Skip to Main Content

Paper Details

Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States.
Pancreas
24
2020

Datasets

Release 1.2